DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $930,126 | +3.4% | 3,749 | 0.0% | 0.31% | +6.5% |
| Q2 2023 | $899,760 | -4.8% | 3,749 | 0.0% | 0.29% | -14.4% |
| Q1 2023 | $944,897 | -5.0% | 3,749 | 0.0% | 0.34% | -7.8% |
| Q4 2022 | $995,059 | +2.0% | 3,749 | -0.8% | 0.37% | -9.3% |
| Q3 2022 | $976,000 | +2.7% | 3,779 | +0.8% | 0.41% | +15.3% |
| Q2 2022 | $950,000 | -13.6% | 3,749 | 0.0% | 0.35% | +0.6% |
| Q1 2022 | $1,100,000 | -10.8% | 3,749 | 0.0% | 0.35% | -11.6% |
| Q4 2021 | $1,233,000 | +8.1% | 3,749 | 0.0% | 0.40% | -3.2% |
| Q3 2021 | $1,141,000 | +8.9% | 3,749 | -4.0% | 0.41% | +11.7% |
| Q2 2021 | $1,048,000 | +21.0% | 3,904 | +1.4% | 0.37% | +7.9% |
| Q1 2021 | $866,000 | +1.3% | 3,849 | 0.0% | 0.34% | -8.1% |
| Q4 2020 | $855,000 | +3.1% | 3,849 | 0.0% | 0.37% | -4.1% |
| Q3 2020 | $829,000 | +18.1% | 3,849 | -3.1% | 0.39% | +16.6% |
| Q2 2020 | $702,000 | +20.2% | 3,974 | -5.8% | 0.33% | -5.7% |
| Q1 2020 | $584,000 | -9.9% | 4,220 | 0.0% | 0.35% | +0.9% |
| Q4 2019 | $648,000 | +6.2% | 4,220 | 0.0% | 0.35% | -3.9% |
| Q3 2019 | $610,000 | -25.4% | 4,220 | -26.2% | 0.36% | -27.3% |
| Q2 2019 | $818,000 | -4.4% | 5,720 | -11.8% | 0.50% | -6.7% |
| Q1 2019 | $856,000 | +179.7% | 6,486 | +118.3% | 0.54% | +148.8% |
| Q4 2018 | $306,000 | -12.1% | 2,971 | -7.3% | 0.22% | -6.9% |
| Q3 2018 | $348,000 | -17.1% | 3,205 | -24.6% | 0.23% | -46.5% |
| Q2 2018 | $420,000 | -5.8% | 4,250 | -6.6% | 0.43% | -8.3% |
| Q1 2018 | $446,000 | +1.4% | 4,552 | -3.9% | 0.47% | +1.3% |
| Q4 2017 | $440,000 | -2.2% | 4,735 | -9.7% | 0.46% | -9.5% |
| Q3 2017 | $450,000 | -8.5% | 5,245 | -9.9% | 0.51% | -5.2% |
| Q2 2017 | $492,000 | -11.0% | 5,822 | -9.9% | 0.54% | -24.0% |
| Q1 2017 | $553,000 | -7.8% | 6,465 | -16.1% | 0.71% | -4.4% |
| Q4 2016 | $600,000 | 0.0% | 7,703 | +0.6% | 0.75% | -4.6% |
| Q3 2016 | $600,000 | -23.8% | 7,656 | -1.8% | 0.78% | -21.7% |
| Q2 2016 | $787,000 | +4.9% | 7,795 | -1.4% | 1.00% | +7.2% |
| Q1 2016 | $750,000 | +0.5% | 7,909 | -1.5% | 0.93% | +5.4% |
| Q4 2015 | $746,000 | +7.8% | 8,027 | -1.2% | 0.88% | +2.1% |
| Q3 2015 | $692,000 | +33.3% | 8,123 | +34.0% | 0.87% | +42.7% |
| Q2 2015 | $519,000 | – | 6,063 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |